Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study.

disc hemorrhage flicker chronoscopy fundus photography primary open-angle glaucoma progression prospective cohort study prostaglandin analogues visual field

Journal

Ophthalmology. Glaucoma
ISSN: 2589-4196
Titre abrégé: Ophthalmol Glaucoma
Pays: United States
ID NLM: 101730510

Informations de publication

Date de publication:
21 Aug 2020
Historique:
received: 24 06 2020
revised: 12 08 2020
accepted: 17 08 2020
pubmed: 25 8 2020
medline: 25 8 2020
entrez: 25 8 2020
Statut: aheadofprint

Résumé

To investigate the spatial and temporal relationship between disc hemorrhage (DH) and structural progression in patients with primary open-angle glaucoma (POAG) in a 3-year prospective study. Prospective cohort study. Patients with POAG and intraocular pressure of ≤18 mmHg on monotherapy with prostaglandin analogs. Fundus photographs were taken at baseline and every 3 months for 3 years. Disc hemorrhage and structural progression were detected independently by flicker chronoscopy. If present, clock-hour disc locations in the right eye format and colocalization were determined. Statistical comparisons were based on mixed-effects models accounting for the correlation between different disc sites within the same eye and between fellow eyes in the same patient. Relationship between DH and structural progression at the same site. Among 195 eyes of 115 patients, DH appeared in 85 sites in 65 eyes (33.3%) and was most frequently at the 7 o'clock disc location (29.4%, P < 0.0001). Structural progression occurred at 63 sites of 52 eyes (26.7%) comparably in both superior and inferior hemidiscs, which was mostly detected as widening of the retinal nerve fiber layer defects (RNFLDs). Temporal RNFLD widening was common, whereas nasal widening occurred exclusively in the vertical quadrants (P = 0.035). Of 41 progression sites in eyes with DH, 28 sites (68.2%) had both DH and progression. Progression sites with DH were less common in the superior quadrant than in the inferior and temporal quadrants (P = 0.011). Eyes with DH had a significantly higher risk of progression than eyes without DH (hazard ratio, 3.72; P < 0.0001). For 63 progression sites, DH recurrence and more visits with DH at the progression site were significantly associated with shorter time to progression from baseline (P = 0.021, P = 0.017, respectively), whereas colocalization of DH and progression were not. In a 3-year prospective study with a Japanese POAG cohort, the relationship between DH and RNFLD and the pattern of RNFLD progression differed by disc location. The association between more frequent DH at the progression site and shorter time to progression indicates that DH may reflect vulnerability to same-site structural deterioration.

Identifiants

pubmed: 32835837
pii: S2589-4196(20)30220-9
doi: 10.1016/j.ogla.2020.08.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Auteurs

Tomomi Higashide (T)

Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. Electronic address: eyetomo@med.kanazawa-u.ac.jp.

Shinji Ohkubo (S)

Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.

Sachiko Udagawa (S)

Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.

Kazuhisa Sugiyama (K)

Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.

Hidenobu Tanihara (H)

Department of Ophthalmology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Makoto Araie (M)

Kanto Central Hospital of The Mutual Aid Association of Public School Teachers, Tokyo, Japan.

Goji Tomita (G)

Department of Ophthalmology, Toho University Ohashi Medical Center, Tokyo, Japan.

Chota Matsumoto (C)

Department of Ophthalmology, Kindai University Faculty of Medicine, Osaka, Japan.

Takeo Fukuchi (T)

Division of Ophthalmology and Visual Science, Graduate School of Medical and Dental Science, Niigata University, Niigata, Japan.

Atsuo Tomidokoro (A)

Higashi Nakano Tomidokoro Eye Clinic, Tokyo, Japan.

Masanori Hangai (M)

Hangai Eye Institute, Saitama, Japan.

Hisashi Kawata (H)

Clinical Development Center, R&D Division, Santen Pharmaceutical Co, Ltd, Osaka, Japan.

Maya Inai (M)

Clinical Development Center, R&D Division, Santen Pharmaceutical Co, Ltd, Osaka, Japan.

Yuki Tanaka (Y)

Clinical Development Center, R&D Division, Santen Pharmaceutical Co, Ltd, Osaka, Japan.

Classifications MeSH